Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C19H22N2OS |
| Molecular Weight | 326.456 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(C)CCN1C2=CC=CC=C2SC(CC1=O)C3=CC=CC=C3
InChI
InChIKey=QJJXOEFWXSQISU-UHFFFAOYSA-N
InChI=1S/C19H22N2OS/c1-20(2)12-13-21-16-10-6-7-11-17(16)23-18(14-19(21)22)15-8-4-3-5-9-15/h3-11,18H,12-14H2,1-2H3
| Molecular Formula | C19H22N2OS |
| Molecular Weight | 326.456 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Thiazesim (also known as ) is a benzothiazepine derivative patented by Olin Mathieson Chemical Corp. as an oral anti-depressant and tranquilizer useful in the treatment of Parkinsonism. Thiazesim is chemically related to the tranquilizing drugs chlordiazepoxide and diazepam but possesses a unique action on the limbic system, namely a selective depression of the lateral amygdaloid nucleus in experimental animals. Thiazesim shows potent anti-depressant activity in clinical trials.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/4867805
100 mg. t.d.s., and increased after one week if no clinical effects had been noted
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:12:49 GMT 2025
by
admin
on
Mon Mar 31 19:12:49 GMT 2025
|
| Record UNII |
44G76ZB85O
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C265
Created by
admin on Mon Mar 31 19:12:49 GMT 2025 , Edited by admin on Mon Mar 31 19:12:49 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
44G76ZB85O
Created by
admin on Mon Mar 31 19:12:49 GMT 2025 , Edited by admin on Mon Mar 31 19:12:49 GMT 2025
|
PRIMARY | |||
|
2169
Created by
admin on Mon Mar 31 19:12:49 GMT 2025 , Edited by admin on Mon Mar 31 19:12:49 GMT 2025
|
PRIMARY | |||
|
100000082181
Created by
admin on Mon Mar 31 19:12:49 GMT 2025 , Edited by admin on Mon Mar 31 19:12:49 GMT 2025
|
PRIMARY | |||
|
22107
Created by
admin on Mon Mar 31 19:12:49 GMT 2025 , Edited by admin on Mon Mar 31 19:12:49 GMT 2025
|
PRIMARY | |||
|
2627
Created by
admin on Mon Mar 31 19:12:49 GMT 2025 , Edited by admin on Mon Mar 31 19:12:49 GMT 2025
|
PRIMARY | |||
|
SUB11014MIG
Created by
admin on Mon Mar 31 19:12:49 GMT 2025 , Edited by admin on Mon Mar 31 19:12:49 GMT 2025
|
PRIMARY | |||
|
DTXSID30863620
Created by
admin on Mon Mar 31 19:12:49 GMT 2025 , Edited by admin on Mon Mar 31 19:12:49 GMT 2025
|
PRIMARY | |||
|
C152585
Created by
admin on Mon Mar 31 19:12:49 GMT 2025 , Edited by admin on Mon Mar 31 19:12:49 GMT 2025
|
PRIMARY | |||
|
C003436
Created by
admin on Mon Mar 31 19:12:49 GMT 2025 , Edited by admin on Mon Mar 31 19:12:49 GMT 2025
|
PRIMARY | |||
|
CHEMBL2111123
Created by
admin on Mon Mar 31 19:12:49 GMT 2025 , Edited by admin on Mon Mar 31 19:12:49 GMT 2025
|
PRIMARY | |||
|
m10727
Created by
admin on Mon Mar 31 19:12:49 GMT 2025 , Edited by admin on Mon Mar 31 19:12:49 GMT 2025
|
PRIMARY | Merck Index | ||
|
Tiazesim
Created by
admin on Mon Mar 31 19:12:49 GMT 2025 , Edited by admin on Mon Mar 31 19:12:49 GMT 2025
|
PRIMARY | |||
|
5845-26-1
Created by
admin on Mon Mar 31 19:12:49 GMT 2025 , Edited by admin on Mon Mar 31 19:12:49 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |